StonvexLoading…
StonvexStonvexStonvexCore line items from CNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.16B | $2.16B | $2.51B | $2.28B |
Operating Income | $-182.06M | $351.00M | $803.34M | $568.44M |
Net Income | $-153.22M | $286.40M | $655.89M | $466.98M |
EPS (Diluted) | $-2.98 | $9.61 | $19.79 | $13.07 |
Total Assets | $6.13B | $2.88B | $2.68B | $2.70B |
Total Liabilities | $2.45B | $1.31B | $1.33B | $1.54B |
Cash & Equivalents | $432.17M | $408.24M | $199.37M | $273.07M |
Free Cash Flow OCF − CapEx | $21.17M | $298.40M | $690.16M | $479.48M |
Shares Outstanding | 50.98M | 29.41M | 29.91M | 34.75M |